Reduced neutralisation of the Delta (B.1.617.2) SARS-CoV-2 variant of concern following vaccination

The COVID-19 Genomics UK (COG-UK) Consortium, the COVID-19 DeplOyed VaccinE (DOVE) Cohort Study investigators, Chris Davis, Nicola Logan, Grace Tyson, Richard Orton, William T. Harvey, Jonathan S. Perkins, Guy Mollett, Rachel M. Blacow, Thomas P. Peacock, Wendy S. Barclay, Peter Cherepanov, Massimo Palmarini, Pablo R. Murcia, Arvind H. Patel, David L. Robertson, John Haughney, Emma C. Thomson, Brian J. WillettMatthew Bashton, Darren Smith, Andrew Nelson, Greg Young, Clare McCann, Wen Yew

Research output: Contribution to journalArticlepeer-review

65 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Reduced neutralisation of the Delta (B.1.617.2) SARS-CoV-2 variant of concern following vaccination'. Together they form a unique fingerprint.

Medicine and Dentistry